InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| THP1-Dual™ Cells | Structural insights into a shared mechanism of human STING activation by a po... | 2022 | Cell Discov. | Xie Z. et al. | DOI: 10.1038/s41421-022-00481-4 |
| QUANTI-Luc™: Luciferase Detection Reagent | Structural insights into a shared mechanism of human STING activation by a po... | 2022 | Cell Discov. | Xie Z. et al. | DOI: 10.1038/s41421-022-00481-4 |
| THP1-Dual™ KO-STING Cells | Structural insights into a shared mechanism of human STING activation by a po... | 2022 | Cell Discov. | Xie Z. et al. | DOI: 10.1038/s41421-022-00481-4 |
| QUANTI-Blue™ | Structural insights into a shared mechanism of human STING activation by a po... | 2022 | Cell Discov. | Xie Z. et al. | DOI: 10.1038/s41421-022-00481-4 |
| 293-Dual™ hSTING-H232 Cells | Structural insights into a shared mechanism of human STING activation by a po... | 2022 | Cell Discov. | Xie Z. et al. | DOI: 10.1038/s41421-022-00481-4 |
| STING | Structural insights into a shared mechanism of human STING activation by a po... | 2022 | Cell Discov. | Xie Z. et al. | DOI: 10.1038/s41421-022-00481-4 |
| RAW-Lucia™ ISG-KO-STING Cells | Structural insights into a shared mechanism of human STING activation by a po... | 2022 | Cell Discov. | Xie Z. et al. | DOI: 10.1038/s41421-022-00481-4 |
| 293-Dual™ hSTING-R232 Cells | Structural insights into a shared mechanism of human STING activation by a po... | 2022 | Cell Discov. | Xie Z. et al. | DOI: 10.1038/s41421-022-00481-4 |
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | Alveolar macrophages instruct CD8+ T cell expansion by antigen cross-presenta... | 2022 | Cell Rep. | Kawasaki T. et al. | DOI: 10.1016/j.celrep.2022.111828 |
| MPLA Synthetic VacciGrade™ | Monophosphoryl lipid A ameliorates radiation-induced lung injury by promoting... | 2022 | J Transl Med. | Guo X. et al. | DOI: 10.1186/s12967-022-03804-x |
| Anti-mouse Dectin-1 (CLEC7A) antibody | Single-cell microglial transcriptomics during demyelination defines a microgl... | 2022 | Mol Neurodegener. | Zia S. et al. | DOI: 10.1186/s13024-022-00584-2 |
| HT29-Lucia™ AhR Cells | Graphene oxide elicits microbiome-dependent type 2 immune responses via the a... | 2022 | Nat Nanotechnol. | Peng G. et al. | DOI: 10.1038/s41565-022-01260-8 |
| Primocin® | OrBITS: label-free and time-lapse monitoring of patient derived organoids for... | 2022 | Cell Oncol (Dordr). | Deben C. et al. | DOI: 10.1007/s13402-022-00750-0 |
| AddaVax™ | Ferret model to mimic the sequential exposure of humans to historical H3N2 in... | 2023 | Vaccine | Chiba S. et al. | DOI: 10.1016/j.vaccine.2022.12.005 |
| G418 (Geneticin) | Ferret model to mimic the sequential exposure of humans to historical H3N2 in... | 2023 | Vaccine | Chiba S. et al. | DOI: 10.1016/j.vaccine.2022.12.005 |
| Alhydrogel® adjuvant 2% | Ferret model to mimic the sequential exposure of humans to historical H3N2 in... | 2023 | Vaccine | Chiba S. et al. | DOI: 10.1016/j.vaccine.2022.12.005 |
| Zeocin® | Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines. | 2023 | Chem Eng J. | Li J. et al. | DOI: 10.1016/j.cej.2022.140930 |
| Mouse TLR4 HEK293 Reporter Cells (NF-κB and IL-8) | Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines. | 2023 | Chem Eng J. | Li J. et al. | DOI: 10.1016/j.cej.2022.140930 |
| Hygromycin B Gold | Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines. | 2023 | Chem Eng J. | Li J. et al. | DOI: 10.1016/j.cej.2022.140930 |
| Poly(I:C) (HMW) VacciGrade™ | Efficacy and Safety of Native and Recombinant Zona Pellucida Immunocontracept... | 2022 | Vaccines (Basel). | French H. et al. | DOI: 10.3390/vaccines10121999 |